Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
180 Life Sciences | ATNF | Sep 13, 2024 | 1.81 | -9.50 |
22nd Century Group | XXII | Sep 13, 2024 | 0.34 | +27.07 |
23andMe | ME | Sep 13, 2024 | 0.34 | +4.49 |
2seventy bio | TSVT | Sep 13, 2024 | 4.71 | +2.61 |
4D Molecular Therapeutics | FDMT | Sep 13, 2024 | 16.25 | +2.14 |
60 Degrees Pharmaceuticals | SXTP | Sep 13, 2024 | 1.38 | +1.50 |
AbbVie | ABBV | Sep 13, 2024 | 194.21 | +0.10 |
AbCellera Biologics | ABCL | Sep 13, 2024 | 2.75 | +2.61 |
Abeona Therapeutics | ABEO | Sep 13, 2024 | 5.58 | 0.00 |
Abivax SA - American Depositary Shares | ABVX | Sep 13, 2024 | 11.72 | -2.01 |
Absci | ABSI | Sep 13, 2024 | 3.90 | +5.69 |
ABVC Biopharma | ABVC | Sep 13, 2024 | 0.69 | +0.57 |
Ac Immune SA | ACIU | Sep 13, 2024 | 3.18 | +4.26 |
Acadia Pharmaceuticals | ACAD | Sep 13, 2024 | 16.32 | +2.32 |
Acasti Pharma A | ACST | Sep 13, 2024 | 2.29 | +7.75 |
Accel Entertainment | ACEL | Sep 13, 2024 | 11.65 | +2.01 |
Accelerate Diagnostics | AXDX | Sep 13, 2024 | 1.52 | +1.33 |
Acelyrin | SLRN | Sep 13, 2024 | 4.70 | -5.43 |
Achieve Life Sciences | ACHV | Sep 13, 2024 | 4.53 | +4.14 |
Achilles Therapeutics ADR | ACHL | Sep 13, 2024 | 0.72 | +1.80 |
Aclaris Therapeutics | ACRS | Sep 13, 2024 | 1.18 | +0.85 |
Acrivon Therapeutics | ACRV | Sep 13, 2024 | 8.91 | -3.57 |
Actinium Pharmaceuticals | ATNM | Sep 13, 2024 | 1.86 | -5.10 |
Actuate Therapeutics | ACTU | Sep 13, 2024 | 8.01 | 0.00 |
Acumen Pharmaceuticals | ABOS | Sep 13, 2024 | 2.60 | +6.12 |
Acurx Pharmaceuticals | ACXP | Sep 13, 2024 | 2.04 | +1.49 |
Adagene ADR | ADAG | Sep 13, 2024 | 3.49 | +16.72 |
Adagio Medical | ADGM | Sep 13, 2024 | 4.08 | 0.00 |
Adaptimmune Therapeutics ADR | ADAP | Sep 13, 2024 | 1.11 | +0.91 |
Adaptive Biotechnologies | ADPT | Sep 13, 2024 | 4.61 | +7.21 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.